The annual list compiled by Clarivate identifies scholars whose work has been referenced most often in studies published by other researchers.
Research brief: In a lab study, a UCLA-led team found that verteporfin stopped the replication of SARS-CoV-2, the virus that causes COVID-19.
Past injustices like the Tuskegee Syphilis Study are less likely to spark mistrust than poor interactions with physicians, UCLA psychologists say.
Inspired by creatures that survive in harsh environments, a UCLA team has invented a polymer with the potential to extend the shelf life and reach of medications.
Aparna Bhaduri is leading the fight against the deadliest form of cancer.
The two grant projects, funded by the National Institutes of Health and the Department of Defense, will be led by Dr. Jerzy Kupiec-Weglinski.
With stories from across campus, we pay tribute to some of UCLA’s remarkable graduating students.
A partnership with a local placement agency has facilitated the hiring of 11 employees, with plans to expand soon.
The advance could have implications for drug development and biological research.
The oral medication, ERAS-801, targets a rogue gene found in about 60% of people with the aggressive form of brain cancer.
Dr. Haig Aintablian, who recently completed his residency in emergency medicine at UCLA, is the program’s inaugural fellow.
Research brief: Six months after the shot, nearly 96% of study participants in North Kivu Province still had antibodies in their blood.
Research brief: Additional services to monitor the drug’s potential side effects account for nearly 20% of its total costs, a UCLA-led study shows.
The UCLA–developed diagnostic technology has helped keep the university and other large client organizations operational during the pandemic.
Chancellor Gene Block tours the COVID-19 testing lab, as processes automate and capacity expands.
Bruin Carly Daniels, who leads the Pfizer scientists developing vaccines for pneumonia and the coronavirus, always remembers that patients are waiting.
The five-year award from California’s stem cell agency will help prepare young scientists and physicians to become leaders in the regenerative medicine field.
A UCLA study shows that in the 2000s, physicians prescribed opioids more frequently to whites suffering from back pain than to patients of color.
A UCLA clinical trial provides evidence that the prescription drug varenicline can aid those who want to quit smoking and reduce their drinking.
Professors Robert Damoiseaux and Vaithilingaraja Arumugaswami led a collaboration among scientists from the U.S. and Germany.
Leading the research for UCLA are Istvan Mody, Varghese John and S. Thomas Carmichael.
Research brief: An approach pioneered at UCLA predicts which methicillin-resistant Staphylococcus aureus infections are likely to be cured with antibiotic therapy.
Research brief: The study is aimed at helping doctors ensure their patients adhere to medication regimens.
Despite a government initiative to improve access to end-of-life painkillers, dispensing levels in the wealthiest areas still far outpace the rest of the country.
About 480 health care workers are expected to be vaccinated today.